π Ranked Hypotheses
#1: Context-dependent SCFA modulation informed by ApoE genotype
APOE
computational
Score: 0.674
Seo et al. (2023, Science) showed SCFAs are paradoxically neurotoxic in ApoE4 tauopathy. Stratify by ApoE genotype: reduce SCFAs in ApoE4 tau-positive patients, increase in ApoE3/2 amyloid-positive. Resolves the field's central paradox.
$10,000
estimated over 3 months
mechanistic plausibility
0.88
therapeutic potential
0.85
competitive landscape
0.95
#2: Indole-3-propionic acid (IPA) supplementation as neuroprotective postbiotic
AHR
wet_lab_basic
Score: 0.678
IPA is a gut bacterial tryptophan metabolite that activates AhR, inhibits NF-ΞΊB and NLRP3 inflammasome. Lower blood IPA associated with AD. Defined small molecule β more reproducible than probiotics.
$25,000
estimated over 6 months
mechanistic plausibility
0.78
therapeutic potential
0.72
competitive landscape
0.90
#3: TMAO-lowering via TMA-lyase inhibitors for amyloid reduction
FMO3
wet_lab_basic
Score: 0.648
TMAO activates NLRP3 inflammasome, promotes AΞ² aggregation, disrupts BBB. MR supports causality. Targeting gut TMA-lyase (CutC/D) with DMB or fluoromethylcholine reduces TMAO at source.
$25,000
estimated over 6 months
mechanistic plausibility
0.82
therapeutic potential
0.75
competitive landscape
0.82
#4: Precision FMT from cognitively healthy elderly donors for MCI
MICROBIOME
wet_lab_basic
Score: 0.597
FMT from AD patients causally transfers cognitive deficits (Grabrucker 2023, Brain). Reverse FMT from healthy elderly with high Faecalibacterium/Roseburia and confirmed AD-biomarker negativity.
$25,000
estimated over 6 months
mechanistic plausibility
0.85
therapeutic potential
0.80
competitive landscape
0.70
#5: Mediterranean diet + SCFA modulation for preclinical AD prevention
DIET
wet_lab_basic
Score: 0.588
Med/MIND diet increases SCFA-producing bacteria, associated with lower amyloid/tau. Neurosyn240 reduced amyloid in 5xFAD mice. Cheapest, safest approach for at-risk APOE4 carriers.
$25,000
estimated over 6 months
mechanistic plausibility
0.72
therapeutic potential
0.65
competitive landscape
0.30
π¬ Agora Debate Transcript
THEORIST (LITREVIEW)
Literature Synthesis
124 papers searched. Three landmark 2023 papers shifted field from correlation to causation. SCFA paradox (Seo, Science 2023) is the key finding: germ-free conditions protect against tau, SCFAs reverse this protection in ApoE4 context. TMAO has MR-supported causal role. IPA emerging as neuroprotective biomarker.
SKEPTIC (COORDINATOR)
Critical Analysis
Causality direction unclear in humans (WashU 5-year study ongoing). No large RCT with amyloid/tau biomarker endpoints. Regional microbiome variability complicates universal diagnostics. GV-971 China approval controversial. SCFA effects are context-dependent, making simple supplementation risky.
SYNTHESIZER (COORDINATOR)
Scoring & Ranking
5 hypotheses generated and scored. ApoE-stratified SCFA modulation highest on explore axis (novelty 0.92) β resolves the field's central paradox. IPA supplementation highest feasibility+safety combination. Mediterranean diet safest but least novel.
πΈοΈ Knowledge Graph Updates
mechanism
Gut Microbiome
β produces β
mechanism
SCFAs
mechanism
SCFAs + ApoE4
β worsens (Seo 2023) β
mechanism
Tau pathology
protein
TMA-lyase
β produces β
mechanism
TMAO
mechanism
TMAO
β activates β
mechanism
NLRP3 / AΞ² aggregation
mechanism
Tryptophan
β gut bacteria convert β
mechanism
IPA
mechanism
IPA
β activates β
pathway
AhR / neuroprotection
drug
GV-971
β remodels β
mechanism
Gut microbiota
gene
APOE4
β enables β
mechanism
SCFA neurotoxicity